Application of radioactive particle interstitial implant brachytherapy in the treatment of malignant adenogenous tumors invaded into cranial base area
10.3969/j.issn.1001-3733.2017.06.018
- VernacularTitle:放射性粒子组织间植入近距离放疗在颅底腺源性恶性肿瘤治疗中的应用
- Author:
Ning XU
1
;
Lei ZHENG
;
Jie ZHANG
;
Mingwei HUANG
;
Shuming LIU
;
Xiaoming LV
;
Yan SHI
;
Jianguo ZHANG
Author Information
1. 北京大学口腔医学院口腔颌面外科
- Keywords:
125I seeds;
Brachytherapy;
Cranial base area;
Adenogenous malignant tumor
- From:
Journal of Practical Stomatology
2017;33(6):798-801
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To study the effects of brachytherapy with 125I in the treatment of malignant adenogenous tumors invaded into cranial base area,and to evaluate the correlative factors of prognosis.Methods:24 patients with malignant adenogenous tumors invaded into cranial base area were treated by 125I seeds implanted into the tumors with the spacing of 1-1.5 cm and guided by CT,individual guide plate and navigation system respectively or in combination with the dose of 60-160 Gy.Survival rate,local recurrence rate,distant metastasis and safty of the treatment were evaluated.The correlative factors of prognosis included age,pathology diagnosis,diameter of the tumor,area of tumor invasion and history of radiotherapy were analyzed.Results:The follow-up time of the patients was 3-76 months and the median was 27 months.2 patients came up with radiotherapy reaction of level 4.The total survival rate was 41.7％,the local recurrence rate was 25.0％ and the distant metastasis rate was 37.5％.The cumulative survival rate of 1,3 and 5 years was 79％,67％ and 24％ respectively.Significant correlation was found between prognosis and local recurrence as well as the diameter of the tumor.Conclusion:125I brachytherapy provides a safe and feasible technique with minimal damage for treating malignant adenogenous tumors invaded into cranial base area.The prognosis is related to local recurrence and the diameter of the tumor.
